Thus, GR inhibition decreases ADPC and CRPC prostate cancer cell growth and enhances the cell growth inhibitory effect of enzalutamide (Figure 4H, I, Supplementary Figure S11, S17) ((23,43,51,52). The gene discussed is NR3C1; the disease is Familial prostate cancer.